



Koala retrovirus is thought to be an underlying cause of high levels of neoplasia and 2 
immunosuppression in koalas. While epidemiology studies suggest a strong link between KoRV and 3 
disease it has been difficult to prove causality because of the complex nature of the virus, which exists 4 
in both endogenous and exogenous forms. It has been difficult to identify koalas completely free of 5 
KoRV, and infection studies in koalas or koala cells are fraught with ethical and technical difficulties, 6 
respectively. This study uses KoRV infection of the susceptible human cell line HEK293T and RNAseq 7 
to demonstrate gene networks differentially regulated upon KoRV infection. Many of the pathways 8 
identified are those associated with viral infection, such as cytokine receptor interactions and interferon 9 
signalling pathways, as well as viral oncogenesis pathways. This study provides strong evidence that 10 
KoRV does indeed behave similarly to infectious retroviruses in stimulating antiviral and oncogenic 11 
cellular responses. In addition, it provides novel insights into KoRV oncogenesis with the identification 12 
of a group of histone family genes that are part of several oncogenic pathways as upregulated in KoRV 13 
infection.  14 
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1. Introduction 18 
Koala retrovirus, a gammaretrovirus, is currently undergoing the transition between being an exogenous 19 
(non-inherited and horizontally transmitted) virus to being an endogenous (inherited and vertically 20 
transmitted) virus integrated in the host’s genome (Tarlinton et al., 2006). The virus is linked to 21 
neoplasia and clinical chlamydial disease in koalas with high viral loads (Tarlinton et al., 2005; Legione 22 
et al., 2017; Waugh et al., 2017). It was thought to be absent in some southern populations but recent 23 
work has demonstrated that at least some of these animals do in fact have defective KoRV transcripts 24 
(Tarlinton et al., 2017). It is difficult to demonstrate causality of a disease process to an endogenous 25 
virus that is present in all or most animals but transcriptomic analysis comparing animals from a 26 
population with a high viral load (Queensland, QLD) to animals from a population with a low viral load 27 
and defective KoRV transcripts demonstrated differential expression of pathways concerned with B and 28 
T lymphocyte regulation and oncogenesis (unpublished data). As obtaining completely KoRV free 29 
primary koala cell lines is technically difficult (and may be impossible given recent findings (Tarlinton 30 
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et al., 2017)) and the koala transcriptome not comprehensively annotated, this study has taken the 31 
approach of infecting well characterised continuous human cell lines with KoRV to analyse the cellular 32 
response to KoRV infection.  33 
KoRV was categorized into several KoRV subgroups based on the phylogenetic relationships and the 34 
receptor binding differences of the env gene: KoRV-A (Hanger et al., 2000), KoRV-B (Xu et al., 35 
2013b), KoRV-C, KoRV-D (Shojima et al., 2013), KoRV-E, KoRV-F (Xu et al., 2015), KoRV-G, 36 
KoRV-H, and KoRV-I (Chappell et al., 2017). For other retroviruses, mutation or recombination 37 
events in env genes play a significant role in pathogenicity, such as immunosuppression with variants 38 
of feline leukaemia virus, but the role of KoRV variants in causing specific types of disease has not yet 39 
been resolved (Overbaugh et al., 1988; Anderson et al., 2000; Chandhasin et al., 2005). A recent study 40 
hypothesized that KoRV-D and KoRV-E are defective viruses (Hobbs et al., 2017). It has also been 41 
hypothesized that KoRV-B is more pathogenic and is thought to play a significant role in neoplasia and 42 
chlamydia disease occurrence (Xu et al., 2013b; Waugh et al., 2017; Quigley et al., 2018). 43 
Upon infection of a target cell, retroviruses utilise the host-cellular machinery to finish their life cycles. 44 
Following viral entry into the host cell, viral RNA is reverse transcribed and afterwards integrated into 45 
the cellular genome and the host’s cell machinery is then used for generation of viral transcripts. 46 
Regarding this subsequent replication process, viral factors affect the normal cellular functions due to 47 
interaction with multiple cellular genes and proteins (Kenyon and Lever, 2011). These virus interactions 48 
mediate changes in cellular biological or physiological processes, which can be determined on a 49 
transcriptional level as demonstrated in Human immunodeficiency virus (HIV) (Giri et al., 2006), Feline 50 
immunodeficiency virus (FIV) (Ertl and Klein, 2014) or Reticuloendotheliosis virus (REV) (Miao et 51 
al., 2015).  High throughput approaches such as transcriptome analysis by next generation sequencing 52 
(RNA-seq) techniques have been used in several in vivo or in vitro retroviral studies to identify 53 
differentially expressed genes from infected host or cell types (Ertl and Klein, 2014; Wu et al., 2018). 54 
The types of changes typically seen indicate immune dysregulation, (particularly interferon stimulated 55 
genes) apoptosis, viral replication and persistence. Therefore, to analyse factors contributing to KoRV 56 
pathogenesis, Human Kidney 293T (HEK293T) cells were co-cultured with KoRV-positive peripheral 57 
blood mononuclear cells (PBMCs). PBMCs were chosen as lymphocytes are likely to be producing 58 
infectious virus and have been used to isolate KoRV in several previous studies (Hanger et al., 2000; 59 
Miyazawa et al., 2011; Xu et al., 2013b). The HEK293T cell line was used as a model for KoRV 60 
infection because it gives high titres when used for retroviral production and is permissive to KoRV 61 
infection via the KoRV A receptor, phosphate transporter receptor Pit1, the human variant of which 62 
binds KoRV A and the KoRV B receptor thiamine transporter 1 THTR1 (Mendoza et al., 2006; 63 
Miyazawa et al., 2011; Xu et al., 2013a). 64 
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This study aimed to compare the transcriptome of KoRV-infected versus uninfected HEK293T cells to 65 
determine the impact of KoRV on host cell gene expression. The output of this study will significantly 66 
contribute to deeper insights into the complex virus-host interactions network in KoRV pathogenesis. 67 
2. Methods 68 
2.1 Culture of Peripheral Blood Mononuclear Cells  69 
Blood samples were collected from 15 koalas presented at Moggill Koala Hospital (MKH), Australia 70 
Zoo Wildlife Hospital (AZWH), RSPCA Wacol and Sea World Paradise Country (SWPC) in South 71 
East QLD. After collection, blood was immediately transferred to an EDTA vacutainer tube (BD 72 
Biosciences, Australia) and transported at +4°C to the University of Queensland, Gatton Campus. 73 
Ethical approval for this study was granted by the University of Queensland (UQ) Animal Ethics 74 
Committee, permit number ANFRA/SVS/461/12 and ANRFA/SVS/445/15, the Queensland 75 
Government Department of Environment and Heritage Protection permit number WISP11989112. 76 
PBMCs were separated from whole blood using Ficoll-Paque PLUS (GE Healthcare). The blood was 77 
diluted with an equal volume of sterile HBSS (without calcium or magnesium) (Sigma Aldrich). Diluted 78 
blood samples were layered onto the Ficoll-Paque solution at 3:4 ratio. The tube was then centrifuged 79 
at 400 g for 30 min at 18°C. The mononuclear cell layer was removed and resuspended in 3 volumes of 80 
Hanks solution and centrifuged at 100 g for 10 min at 18°C. This step was repeated twice. Samples that 81 
were observed to contain a red clump within the washed PBMC pellet were treated to remove RBC 82 
contamination. The pellet was suspended with 1 ml Red cell lysis buffer (Sigma) and incubated at 37°C 83 
for 10 mins, followed by 3 washes with cell culture media. Otherwise the pellet was directly suspended 84 
in 1 ml RPMI1640 growth medium containing 20% heat inactivated fetal calf serum (FCS), 1 mM 85 
sodium pyruvate, 1% MEM non-essential amino acid, 0.2% primocin and 100 units/ml recombinant 86 
interleukin-2. A cell count was performed through gentle mixing of cells with 0.4% trypan blue solution 87 
at 1:1 ratio and counts were done in triplicate using hemocytometer under a 40× objective following 88 
the standard methodology (Louis and Siegel, 2011). Cells were diluted to a concentration of 106 cells/ml 89 
using RPMI1640 growth media. The presence of lymphocytes was checked using a cytospin and 90 
automated GIEMSA stainpack, and examined using a light microscope. The percentage of lymphocytes 91 
was counted manually. 92 
2.2 Cell line 93 
Human embryonic kidney (HEK) 293T cells (kindly provided by Professor Alex Khromykh, School of 94 
Chemistry & Molecular Biosciences, University of Queensland, Australia) were cultured in growth 95 
medium comprising Dulbecco’s modified eagle’s medium (DMEM) containing L-glutamine, glucose, 96 
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sodium pyruvate (Thermofisher Scientific) supplemented with 5% heat-inactivated FCS and 0.25% 97 
primocin (InvivoGen). These cells were cultured at 37°C in a humidified atmosphere of 5% CO2 in air. 98 
2.3 KoRV passage in HEK293T cell cultures 99 
HEK293T cells (~106 cells/ml) were added into growth medium in a T75 culture flask (SARSTEDT) 100 
and incubated for 16 - 20 hrs at 37°C in a humidified atmosphere of 5% CO2 in air. The medium was 101 
removed, and suspensions of freshly isolated and non-stimulated PBMCs with ~106 cells/ml 102 
concentration were directly introduced at 40 - 50% cellular density of HEK293T cells and incubated 103 
for 1 hr at 37°C for cell adsorption. Then growth medium was added, and the cultures incubated at 37°C 104 
until HEK293T cells had reached 100% cell confluency. The confluency was checked using an inverted 105 
microscope every 8 hrs. After 100% confluency was attained, culture medium was removed from the 106 
flask, centrifuged at 500g for 5 min and the supernatant was introduced into a fresh 24hr HEK293T cell 107 
culture flask and passaged in this manner for up to five cycles. At each passage, cells adhering to the 108 
culture flask were harvested through trypsinization, centrifuged and the pellet stored for RNA 109 
extraction. In each co-culture and passage, non-infected HEK293T cell line were used as a control.  110 
Cells were harvested using a cell scraper (Thermofisher Scientific). Following centrifugation, the cell 111 
pellet of each passage was lysed using trizol and RNA was extracted using a Qiagen miRNeasy kit 112 
according to manufacturer’s instructions with on-column DNase digestion (Qiagen) procedure to 113 
remove residual DNA. Quality and concentration of total RNA was assessed by NanoDrop2000 114 
spectrophotometer and 2% agarose gel electrophoresis.  115 
2.4 Quantification of viral RNA 116 
RT-qPCR targeting the pol gene was used to determine the KoRV viral RNA copy number in the cell 117 
pellet (HEK293T infected culture). The previously published real time PCR primers and probe for 118 
KoRV pol gene were used (Tarlinton et al., 2005). Reaction mix for the RT-qPCR consisted of 12.5 µl 119 
of 2x reaction mix, 0.5 µl of SuperScript® III RT/Platinum® Taq Mix (SuperScript® III One-Step RT-120 
PCR System with Platinum® Taq DNA Polymerase, Invitrogen), 1 µl of primers (forward and reverse 121 
10 µM final concentration), 0.5 µl of probe (10 µM final concentration), 5.5 µl of ultrapure water, and 122 
5 µl of template. Cycling conditions were: reverse transcription at 50°C for 30 min, Superscript 123 
platinum taq activation at 95°C for 2 min, followed by 45 cycles of denaturation at 95°C for 15 sec and 124 
annealing/extension at 60°C for 30 sec. Standard curves were prepared for each run using RNA 125 
standards, and results for each run measured against these standard curves. The samples were run in 126 
triplicate on a BioRad CFX 96 system.  127 
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2.5 RNA sequencing through Next Generation sequencing platform 128 
Among 15 cultured samples only five maintained growth until passage five. Five samples of KoRV 129 
infected HEK293T culture pellets with a KoRV viral load >105 copies/ml were taken from passage 4 130 
cells for RNA extraction and were sent to the Ramaciotti Centre for Genomics at the University of NSW 131 
for processing and sequencing. RNA extracted from cell pellets of five non-infected HEK293T cell 132 
cultures was used as a control. RNA quality was checked through an Agilent 2100 Bioanalyzer. The 133 
mRNA library was prepared for sequencing from 1 μg of total RNA using the Illumina TruSeq stranded 134 
mRNA library prep kit. These steps included poly-A pulldown and adapter ligation at both ends. The 135 
paired-end (PE) libraries were sequenced as 2X 76 bp PE using the Illumina NextSeq500 platform. 136 
2.6 RNA-seq Analysis through Bioinformatics tools 137 
The NextSeq500 platform generated four lane reads, which were uploaded into the Galaxy server of 138 
University of Queensland for all subsequent analyses. Forward and Reverse reads over four lanes were 139 
joined using Text manipulation - Concatenate datasets/tail-to-head options. The joined paired end reads 140 
were run through FastQC to check the quality of raw unpaired sequence reads. Trimmomatic (Bolger et 141 
al., 2014) was used to remove TrueSeq3 adapter sequence and low-quality reads to prevent noise from 142 
nonsense reads in downstream analysis. Individual Fastq files were checked for read quality with 143 
FastQC software (version 0.10.1). The trimmed paired reads were mapped to the human reference 144 
genome hg19 using HISAT2 (Kim et al., 2015). Duplicate reads were then removed using PicardTools 145 
- Mark Duplicates - Clean SAM. Mapping statistics were tabulated using SAMTools/Flagstat (Li et al., 146 
2009). Gene read counts were generated with HTSeq-count (http://www-147 
huber.embl.de/users/anders/HTSeq/doc/index.html) using the ‘union’ option and each gene FPKM 148 
(expected number of fragments per kilobase of transcript sequence per million base pairs sequenced) 149 
was calculated based on gene length and counts of paired-end reads mapped to the gene. These counts 150 
were used to identify differential expression of genes (DEGs) among samples with Differential count 151 
models of R/Bioconductor package, EdgeR (Robinson et al., 2010). KoRV infected and uninfected 152 
HEK293T cell line samples were designated as treatment and control group, respectively. Genes having 153 
expression values less than one count per million were removed from both libraries. Ordinary deviance 154 
estimates of Robust dispersion method in the EdgeR package were used to estimate each feature’s 155 
dispersion parameter and false discovery rate (FDR), a value of 0.05 was set to correct the threshold of 156 
p-value. Significantly differentially expressed genes were further filtered with Log 2-fold change ≥ 2. 157 
Gene ontology analyses on biological processes (BP) were performed using The Database for 158 
Annotation, Visualization and Integrated Discovery (DAVID) (Huang da et al., 2009a; Huang da et al., 159 
2009b). The significant enrichment score analysed based on hypergeometric distribution. Following 160 
Benjamaini-Hochberg methodology, the p-value was corrected and p value ≤ 0.05 was considered 161 
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representative of significant gene enrichment. To further investigate the biological pathways involving 162 
the identified DEGs, a Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment 163 
analysis was performed using Cytoscape installed ClueGo plug-in. Multiple enrichment tools were 164 
available but at the time of analysis, the ClueGo plug-in KEGG database was the most recently updated 165 
and thus was selected for use. In this enrichment analysis, a two-sided hypergeometric test was used 166 
following the Human GO database and Bonferroni correction for multiple testing-controlled p-values 167 
and GO with corrected p < 0.05 was considered significantly enriched.  168 
2.7 Genetic diversity of KoRV 169 
To identify KoRV RNA presence and quantify transcript level in the cell line (HEK 293T) after 170 
infection, each infected sample was mapped using HISAT2 tools against KoRV-A (AF151794), KoRV-171 
B (KC779547.1), KoRV-C (AB828005.1), KoRV-D (AB828004.1), KoRV-E (KU533853.1), KoRV-172 
F (KX588025.1), KoRV-G (KX587961.1), KoRV-H (KX588036.1) and KoRV-I (KX587976.1). The 173 
mapped reads were quantified using SALMON tools (Patro et al., 2017), quantification output generates 174 
transcript Length, transcripts per Million (TPM) and estimated number of reads (an estimate of the 175 
number of reads drawn from this transcript given the transcript’s relative abundance and length).  176 
3. RESULTS 177 
3.1 RNA sequencing and assembly 178 
KoRV pol RNA was amplified from the co-culture pellet of PBMC-HEK293T cells from 10 koalas out 179 
of a total 15, consisting of six healthy and four diseased animals.  Results are shown in Table 1. The 180 
cultures from five of these koalas remained KoRV RNA positive at the 4th passage in HEK293T cells. 181 
There was no cytopathic effect observed in the KoRV-positive HEK293T cells compared to uninfected 182 
control cells. Ultimately 10 samples were selected for RNA-seq analysis to characterize the host 183 
transcriptional response to KoRV infection, where five were 4th passage KoRV infected HEK293T 184 
cells, designated as “treated” and five were non-infected HEK293T cells, designated as “control”. 185 
Extracted RNA yields varied between samples giving between 1500-3500 ng/µl total RNA. The 186 
A260/280 ratio of all purified RNA samples was between 2.0 and 2.2 and the A260/230 ratio values of 187 
all samples were greater than 2.0. Gel electrophoresis confirmed that the majority of extracted RNA 188 
samples were present in intact form with no DNA contamination. Using NextSeq500 2x 76 bp Illumina 189 
platform, at least 76 million reads per sample were obtained. After removal of adapter sequences and 190 
low quality reads, samples were mapped against the human reference genome hg19, with at least 85.30 191 
% paired end reads mapped. The mapping percentages are detailed in Table 2. Sequence reads are 192 
available in NCBI database, accession number PRJNA514936. 193 
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The replication of KoRV in the cell line was further confirmed by mapping the sequences against the 194 
full genome of KoRV-A (Accession no AF151794). All “treated” samples were KoRV positive when 195 
mapped against the KoRV-A genome, values are presented as Transcript level per million (TPM) in 196 
Table 3. 197 
3.2 Differentially expressed genes and functional enrichment analysis 198 
To determine the effects of KoRV infection on the host transcriptome, differentially expressed genes 199 
were analysed by comparing KoRV infected and non-infected HEK293T cells. In total, 4701 genes 200 
were significantly differentially expressed (p- value ≤ 0.05). When these were further filtered to identify 201 
genes that were differentially expressed by at least a two-fold log change (up or down), 1458 genes 202 
were identified where 973 genes were up-regulated, and 485 genes were down-regulated. Of these 203 
genes, only 526 up-regulated and 234 downregulated genes were annotated with Homo sapiens, the full 204 
list of genes is presented in supplementary file 1. The distribution of DEGs is presented in Figure 1.  205 
Many immune associated genes were up-regulated in the KoRV infected cells with significantly high 206 
levels of enrichment. For example, genes that showed increased expression included those related to 207 
interferon responses such as IFITM1 (interferon induced transmembrane protein 1; fold change 2), 208 
SECTM1 (secreted and transmembrane 1; fold change 3.1), OAS2 (2'-5'-oligoadenylate synthetase 2; 209 
fold change 2.9) and TNFSF10 (tumor necrosis factor (ligand) superfamily, member 10; fold change 210 
4.2). Other up-regulated immune related genes included chemokine C-C motif ligand (CCL1, CCL2, 211 
CCL5, CCL10 and certain interleukins and their receptors, including IL6, IL8, IL17F, IL32, interleukin 212 
2 receptor alpha (IL2RA) and interleukin 2 receptor gamma (IL2RG).  213 
In contrast, genes showing decreased expression were Micro(mi)RNA, such as microRNA 214 
4442(MIR4442), microRNA 1289-1(MIR1289-1), microRNA 3657(MIR3657), microRNA 215 
548l(MIR548L), and microRNA 221(MIR221). MiRNAs are involved in the regulation of biological 216 
processes, including immune response and apoptosis and their pathogenic role, when dysregulated, has 217 
been widely studied in the malignant diseases and autoimmune disorders (Jakymiw et al., 2006; Long 218 
et al., 2016). Some downregulated genes related to homeostatic processes, such as ARRDC3 (arrestin 219 
domain containing 3; fold change -2.11), SLC24A4 (solute carrier family 24 member 4; fold change -220 
2.49) and SLC26A4 (solute carrier family 26 member 4; fold change -2.36) were also identified.  221 
To further characterize the biological function of the DEGs after KoRV infection, a functional 222 
enrichment GO and KEGG pathway analysis was performed.  Significantly up-regulated DEGs were 223 
involved in 74-biological processes (BP). These included ‘negative regulation of viral genome 224 
replication’, ‘nucleosome assembly’, ‘defense response to virus’, ‘type I interferon signaling pathway’, 225 
‘telomere organization’ and ‘immune response’. Meanwhile, down-regulated DEGs involved 13 BP.  226 
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Some processes were related to cell communication or signalling such as adenylate cyclase-inhibiting 227 
G-protein coupled receptor signalling pathway, G-protein coupled purinergic nucleotide receptor 228 
signalling pathway and phospholipase C-activating G-protein coupled receptor signalling pathway. The 229 
top 10 upregulated and downregulated biological processes are illustrated in Figure 2. The full list is 230 
presented in supplementary file 2 and 3. 231 
The KEGG pathway enrichment results (Figure 3) showed that the DEGs were involved mostly in viral 232 
disease or response pathways with significant overlap in “cytokine-cytokine receptor interaction, 233 
“influenza A”, “herpes simplex infection”, “NOD-like receptor signalling pathway”. Similarly, there 234 
was significant overlap between “viral carcinogenesis, “systemic lupus erythematosus” and 235 
“transcriptional misregulation in cancer”. The alcoholism pathway can be explained by the overlap with 236 
the Systemic lupus erythematosus pathway due to the presence of the histone family gene clusters and 237 
may not be important by itself. Only up-regulated genes were involved in the biological pathways and 238 
none of the down-regulated genes had any association with biological pathways. Genes involved in the 239 
KEGG pathways are listed in supplementary file 4.  240 
3.3 Assessment of KoRV subgroup expression levels  241 
Before proceeding to further analysis, KoRV expression after cell line integration was further confirmed 242 
using mapping against KoRV-A, KoRV-B, KoRV-C , KoRV-D, KoRV-E, KoRV-F, KoRV-G, KoRV-243 
H and KoRV-I. All five infected samples were KoRV-A positive with high TPM values and 3 samples 244 
were additionally KoRV-B positive, with lower TPM values compared to their KoRV-A levels. Results 245 
are depicted in table 3. 246 
4. Discussion 247 
This study was designed to gain insight into host response to KoRV infection and to investigate 248 
pathogenesis upon KoRV infection using RNA-seq based transcriptome analysis of infected and 249 
uninfected cell lines. Our results indicated that there were stark differences in the levels of expression 250 
of certain genes in the host after KoRV infection. The majority of the up-regulated and down-regulated 251 
genes are involved with immune functions and are reflective of an immune response to the viral 252 
challenge. 253 
It had been previously reported that Koala PBMCs could be isolated from whole blood following Ficoll-254 
Hypaque isolation procedure and growth maintained with 9% FCS and 1% koala serum (Miyazawa et 255 
al., 2011). In the current study, PBMCs were isolated from blood following Ficoll-Hypaque isolation 256 
using 20 % FCS instead of koala serum. KoRV was successfully grown in HEK293T cells and virus 257 
replication was steady with each passage, growth didn’t increase markedly with each passage although 258 
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there was a trend to higher copy number in the 4th passage of the cell cultures from 3 koalas, perhaps 259 
suggesting virus was adapting to growth in these cells.  260 
Host response to the initial entry of KoRV into cells was characterised by significant upregulation of 261 
genes involved in the innate immune response and the inhibition of viral replication which was not 262 
unexpected. The innate immune response plays a significant role in viral invasion resistance during 263 
early infection. This is triggered when specific pattern recognition receptor (PRRs) families detect 264 
microbial pathogens and act to increase expression of type I interferons and other cytokines (Kawai and 265 
Akira, 2009). Toll-like receptor 2 (TLR2), which is involved in recognition of viruses and their 266 
products, was characterized as a significantly up-regulated gene (other TLR genes were not 267 
differentially regulated). The up-regulation of toll-like receptors and subsequent effect on inflammatory 268 
response has already been demonstrated in other retrovirus infections such as HIV-1 (Hernandez et al., 269 
2012). 270 
Negative regulation of viral genome replication was characterised as the most significantly up-regulated 271 
biological process. This is not surprising, because activation of this part of the body’s first line of 272 
defence occurs when a virus invades a host. Several interferon (IFN)-stimulated genes (ISG’s) were 273 
significantly up-regulated in this process. Interferon induced transmembrane protein 1 and 3 (IFITM1 274 
and IFITM3) and IFNB1 are part of the network of ISGs, and have previously been shown to have 275 
antiviral properties and an ability to suppress HIV virus replication (Lu et al., 2011). Among other up 276 
regulated genes, TRIM22 (tripartite motif protein 22) is known to inhibit Gag assembly (Barr et al., 277 
2008) and APOBEC3A (apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3A) is 278 
known to limit HIV-1 replication through hypermutation at reverse transcription (Sheehy et al., 2002; 279 
Malim and Emerman, 2008). The JAK-STAT (Janus kinase/signal transducer and activator of 280 
transcriptions) signaling pathway is employed by multiple cytokines and interferons and is crucial for 281 
the development of both innate and adaptive immunity (Yan et al., 2018). However, the up-regulation 282 
of ISGs, which is the hallmark of host response against viral infection, suggests continual, but controlled 283 
expression of viral replication association genes in KoRV infection of HEK293T cells.  284 
As expected, the Cytokine-cytokine receptor interaction pathway was significantly up-regulated in 285 
response to KoRV infection. The 21 significant differently expressed up-regulated genes detected in 286 
this pathway (CCL2, CCL26, CCL5, CSF3R, CXCL1, CXCL10, CXCL8, GH1, GH2, IFNB1, IFNL1, 287 
IFNL2, IFNL3, IL17F, IL2RA, IL2RG, IL6, INHBA, INHBE, TNFRSF14, TNFSF10) may be a set of 288 
genes related to early general host response against infections (Perry et al., 1997; Maher et al., 2014). 289 
Among other chemokines, CCL2 is unique in having enhancing effects on viral replication and 290 
pathogenesis and higher levels are associated with counterproductive immune activation and 291 
inflammation of HIV infected subjects (Covino et al., 2016). IL-6 modulates naive T cells 292 
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differentiation into Th1 or Th2 cells (Diehl and Rincon, 2002; Rodriguez et al., 2010) and has 293 
involvement with increasing inflammation and promoting chlamydial growth (Rodriguez et al., 2010). 294 
The significant up-regulation of IL-6 and CCL2 genes suggests an antiviral immune response which is 295 
expected at earlier infection.  296 
An association between KoRV infection and development of different types of neoplasia including 297 
lymphoid leukaemia, mesothelioma, craniofacial tumor and osteochondroma has been demonstrated 298 
(Tarlinton et al., 2005). The current study investigated the effect of KoRV infection on a cell line to 299 
better understand KoRV pathogenesis. Multiple oncogenes and tumor genes were differentially 300 
expressed. For example, CSF3R which is highly related with leukaemogenesis (Ikewaki et al., 2012) 301 
was upregulated as was MMP9 which contributes significantly to tumour growth and angiogenesis and 302 
is overexpressed in lymphocytic leukaemia (Casabonne et al., 2011). Several oncogenes including REL 303 
(v-rel reticuloendotheliosis viral oncogene homolog (avian)), members of RAS oncogene family, 304 
RAB17 and RAB38, TLX1 (T-cell leukemia homeobox 1) were also identified as being upregulated. 305 
Transcriptional misregulation in cancer and viral carcinogenesis pathways were upregulated, the histone 306 
family genes (HIST1H3B, HIST1H3D, HIST1H3E, HIST1H3H) involved in these pathways are linked 307 
to cell cycle progression defects and DNA damage (Mei et al., 2017). The pathway level analysis of 308 
differentially expressed genes in the network milieu provides novel insights into the pathogenesis of 309 
neoplasia in koalas. However, the results need to be interpreted with some caution as the studied cell 310 
line was not of koala origin and the cells were only infected only for a short time. Tumor development 311 
begins when a cell sustains a genetic mutation that increases its propensity to divide and decreases its 312 
responsiveness to normal growth control mechanisms. Depending on the mutation and cell type this can 313 
lead to one or a series of the following: hyperplasia, dysplasia, and benign, in-situ or invasive cancer. 314 
Clearly, further mechanistic studies to clarify the particular role of the oncogenes and their interaction 315 
with viral proteins in KoRV diseases are warranted. 316 
It would have been preferable to perform this study in a koala cell line. However, there are several 317 
practical difficulties with this approach. There are currently no available continuous cell lines of koala 318 
origin. The cell line reported by (Girjes et al., 2003) proved in the end not to be of koala origin 319 
(unpublished data). Hence all koala cell cultures are currently primary cell lines with limited ability to 320 
sustain passage in cell culture. It has also proven virtually impossible to isolate koala cells that do not 321 
contain KoRV. Animals previously thought to be KoRV-free in southern Australia have been shown in 322 
our recent work (Tarlinton et al., 2017) to have defective variants of the virus missing the polymerase 323 
gene. It is likely that through superinfection interference, these defective KoRV variants would interact 324 
with infectious KoRV in the cell cultures. Thus, without access to koala cell lines or KoRV-free primary 325 
cell cultures, this work was performed in the model system of human HEK293T cells.  326 
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Animals from the QLD populations that these samples were derived from, have been shown to all 327 
possess KoRV-A, with a more variable number also having KoRV B usually present at a 10 fold lower 328 
expression level than KoRV A, consistent with the virus variants seen in this study (Sarker et al., 2019).. 329 
The receptors for KoRV A and B (PiT 1 and THTR1) are both present in the HEK293T cell line so it 330 
is unsurprising that both these variants have been passaged in this cell line. What is more interesting is 331 
the absence of other variants (KoRVs C-I) which are known to be present in the blood of QLD animals 332 
(Chappell et al., 2017; Sarker et al., 2019). In particular the KoRV D variant has been shown to be 333 
present in all animals in this population, in some cases at a 10 fold higher level in the blood than KoRV 334 
A (Quigley et al., 2019). Those variants of KoRV D that have been fully sequence characterised are 335 
replication defective (Hobbs et al., 2017) and may either arise de-novo within animals or require a 336 
helper virus to transmit between animals. The receptors for KoRVs C-I are not known. As subgroups 337 
C-I have not sub-passaged in the HEK293T cells despite almost certainly being present in the original 338 
samples, these appear to be incapable of sustained replication in this human cell line. Whether this is 339 
due to the absence of necessary receptors or the viruses themselves not being fully replication competent 340 
(or a combination of both) remains to be determined. This study certainly supports existing evidence 341 
that the KoRV A and B subgroups are transmissible (Fiebig et al., 2006; Shojima et al., 2013; Xu et al., 342 
2013a) in a variety of non-koala cell lines and animal models. To date, no studies had been conducted 343 
on the association of LTR (long terminal repeat) genetic changes with KoRV disease pathogenicity 344 
although, along with the env gene, LTR also contributes to disease pathogenicity in feline leukaemia 345 
virus (FeLV) infection of cats (Matsumoto et al., 1992) and avian leukosis virus (ALV) in chickens 346 
(Zavala et al., 2007). The LTR of FeLV contains two or three tandem direct repeats of enhancer 347 
elements in lymphoma positive cats, while non-neoplastic strains contain only a single copy of the 348 
enhancer (Miura et al., 1989; Fulton et al., 1990; Matsumoto et al., 1992). A previous study highlighted 349 
the presence of four 17 bp tandem repeats in a KoRV-B isolate LTR while three 37 bp tandem repeats 350 
were found in a KoRV-J isolate LTR and one tandem repeat in KoRV-A (Shimode et al., 2014). It is 351 
possible that differential expression of KoRV env subtypes might be linked with LTR enhancer or 352 
promoter activity.  353 
This study clearly demonstrates that active KoRV infection induces antiviral and oncogenic responses 354 
in a naive human cell line, supporting the hypothesis that KoRV is, like HIV an immunosuppressive 355 
and oncogenic virus. It lends support to the epidemiological evidence that KoRV is the underlying cause 356 
of the very high rates of leukaemia, lymphoma and immunosuppression (leading to chlamydial disease) 357 
seen in koalas (Hanger et al., 2000; Waugh et al., 2017). This study also provides insight into possible 358 
pathogenic mechanisms for neoplasia development in KoRV infected koalas. The study also provides 359 
support to the idea that the KoRV A and B subgroups of virus are fully replication competent and 360 
transmissible with subgroups C-I not demonstrating the ability to be sub-passaged in the human cell 361 
line used in this study.  In the future, the approach and methodology of this study could be applied to 362 
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koala specific cell lines, if those that are completely KoRV free can be identified and maintained in 363 
culture.  364 
 365 
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